Holdings of SAMSARA BIOCAPITAL, LLC
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 22 in 3 countries
- Top ten
- 92.0 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Scholar Rock Holding Corp | 6,897,652 | 339.1M $ | |
| 2 | Mineralys Therapeutics Inc | 5,871,018 | 159M $ | |
| 3 | Alumis Inc | 6,345,219 | 139.8M $ | |
| 4 | Septerna Inc | 3,149,128 | 75.7M $ | |
| 5 | KALARIS THERAPEUTICS INC | 12,948,081 | 74.7M $ | |
| 6 | SpyGlass Pharma Inc | 2,109,953 | 54.7M $ | |
| 7 | Neurogene Inc | 1,717,127 | 34.6M $ | |
| 8 | Inventiva SACA | 5,194,805 | 28.8M $ | |
| 9 | Sutro Biopharma Inc | 1,062,872 | 26.5M $ | |
| 10 | JADE BIOSCIENCES INC | 968,798 | 13.6M $ | |
| 11 | VTV THERAPEUTICS INC | 298,496 | 11.8M $ | |
| 12 | Aquestive Therapeutics Inc | 2,500,000 | 10.4M $ | |
| 13 | X4 PHARMACEUTICALS INC | 1,832,566 | 7.6M $ | |
| 14 | Nkarta Inc | 3,507,666 | 7.4M $ | |
| 15 | Arcellx Inc | 60,873 | 7M $ | |
| 16 | Upstream Bio Inc | 736,047 | 6.6M $ | |
| 17 | Abivax SA | 56,581 | 6.3M $ | |
| 18 | AGOMAB THERAPEUTICS SA | 600,000 | 6.3M $ | |
| 19 | Rani Therapeutics Holdings Inc | 8,500,000 | 6.2M $ | |
| 20 | Coherus Oncology Inc | 3,428,571 | 5.8M $ | |
| 21 | Palvella Therapeutics Inc | 38,432 | 4.8M $ | |
| 22 | Gossamer Bio Inc | 7,222,559 | 2.4M $ |
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 96.0 %
- France 3.4 %
- Belgium 0.6 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 19 | 987.7M $ | 95.97 % |
| 2 | France | 2 | 35.1M $ | 3.41 % |
| 3 | Belgium | 1 | 6.3M $ | 0.61 % |
Cite this page
Titelia. "Holdings of SAMSARA BIOCAPITAL, LLC". https://titelia.com/en/funds/US13F1744967